'The Bloodline with LLS has hit the 10,000 mark with listeners from over 60 countries! On this podcast, Alicia Patten and Lizette Rivera from The Leukemia & Lymphoma Society speak with healthcare professionals, patients and caregivers about the cancer journey in a personable and conversational way. They cover topics ranging from disease-specific information to survivorship issues. This podcast was created to remind you that after a diagnosis comes hope. Subscribe to The Bloodline w...
This new book covers the following topics and includes worksheets to help you get and stay organized. Types of health insurance plans Disability insurance options Benefits and denial of insurance coverage Financial assistance Resources and helpful organizations Cancer and Your Finances Click here to download a PDF or order a copy for free. All of our free information booklets are available at www.LLS.org/booklets.You may also contact an LLS Information Specialist to...
The Nobel Prize in Physiology or Medicine has been awarded today to two scientists whose groundbreaking work led to the development of a class of immunotherapies called checkpoint inhibitors that work by releasing the brakes on the immune system. James P. Allison, Ph.D., chair of department of immunology at MD Anderson Cancer Center in Houston and director of the Cancer Research Institute Scientific Advisory Council, and Tasuku Honjo, M.D., Ph.D., of Kyoto University School of Medicine...
Hearing the words, “you have cancer” rattles your core, regardless of who you are. On this episode, Alicia and Lizette speak with Dr. Marni Amsellem, a clinical psychologist who specializes in working with patients and caregivers who are adjusting to cancer and other health-related challenges and seeking to build their coping skills and resilience. Dr. Amsellem speaks about issues that are experienced by both newly diagnosed patients and patients who are further along in their survivorshi...
Young adult cancer survivors have unique needs, different from pediatric and adult patients. Live on June 21, 2018, the first ever Young Adult Cancer Action Day, The Leukemia & Lymphoma Society spoke with Kate Houghton, President and CEO of Critical Mass of The Young Adult Cancer Alliance, and Sarah Milberg, Senior Manager of Federal Affairs at The Leukemia & Lymphoma Society’s Office of Public Policy in Washington, DC. June 21st is a special day because it marks the introduction of...
Most people are aware of common side effects of cancer treatment such as nausea and hair loss. However, most people who undergo cancer treatment develop complications that affect the mouth. Listen in as Alicia and Lizette speak with Dentist Dr. Nevin Waters, who founded his own practice in 1975 with the goal of treating each patient as he would have a family member. He is an active member of the American Dental Association and founder and board member of the Kansas Foundation of Dentistry fo...
Many may be familiar with graft versus host disease (GVHD) however, veno-occlusive disease (VOD), otherwise known as sinusoidal obstruction syndrome (SOS), is also one of the most frequently encountered complications after stem cell transplantation. Listen in as Alicia and Lizette from The Leukemia & Lymphoma Society (LLS) speak with Dr. Joseph Antin, Chief of the Stem Cell Transplant Program of the Department of Medical Oncology at Dana Farber Cancer Institute and Brigham and Women’s H...
Listen in as Alicia and Lizette speak with psycho-oncologist, Elizabeth Harvey. Elizabeth works with and supports cancer patients, their families and caregivers throughout their cancer journey. Elizabeth has spent over 20 years working in research for cancer drug development and also worked with the late Dr. Jimmie Holland, a Founder of psycho-oncology. Elizabeth shines light on the fact that many times there is failure to address the psychosocial concerns that are associated with cancer. On ...
This post is one in a series of news updates from ASCO. Read more by clicking here and here. The American Society of Clinical Oncology (#ASCO18) annual meeting is an opportunity to show the progress on investigational cancer therapies, better ways to use old medicines and improved methods of diagnosis. One of the interesting themes to emerge over the past few days here in Chicago is the goal of giving less rather than more treatment. The quest to de-escalate treatment helps avoid bo...
Using genomics – analyzing a cancer patient’s genetic profile to identify what is causing the malignancy and then using a drug that will work best for that patient’s subtype of cancer – has been evolving over at least two decades. The approach has accelerated in recent years as the technology has improved. And with it there have been stunning successes along with some disappointments. On Saturday at the American Society of Clinical Oncology meeting (#ASCO18) in Chicago, resu...
&media=https://www.lls.org/sites/default/files/National/USA/Image/get_support/LLS_podcast_Community.jpg){kind=link}
&media=https://www.lls.org/sites/default/files/ASCO.jpg){kind=link}
